Abstract
Accurate analytical data for pharmaceutical dosage forms are dependent on adequate sample preparation and appropriate sample analysis methods. In addition, in order for the results to truly reflect the quality of the overall batch, the sample tested must be representative of the batch. Sampling is the first step and a critical aspect of the overall analysis process. Many analysts, however, are not as familiar with sampling techniques and principles as they are with analytical techniques or even sample preparation techniques. This chapter covers some fundamental sampling considerations and strategies relevant to pharmaceutical dosage forms. Both the theoretical aspects and applications in the development, manufacture, and quality control of pharmaceutical products are discussed. Examples of issues caused by sampling bias/errors are also given.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
21CFR Parts 210 and 211 (1996) Current good manufacturing practice: amendment of certain requirements for finished pharmaceuticals: proposed rule. Federal Register 61(87):20104–20105
Allen T (1997) Particle size measurement powder sampling and particle size measurement, 5th edn. Chapman & Hall, London, pp 1–4
American Society for Quality (2008a) ANSI/ASQ Z1.4 Sampling procedures and tables for inspection by attributes. ASQ, Milwaukee, WI
American Society for Quality (2008b) ANSI/ASQ Z1.9 sampling procedures and tables for inspection by variables for percent nonconforming. ASQ, Milwaukee, WI
American Society for Testing and Materials (2009) ASTM E2709-09 standard practice for demonstrating capability to comply with a lot acceptance procedure. ASTM, West Conshohocken, PA
Bergum JS (1990) Constructing acceptance limits for multiple stage tests. Drug Dev Pharm 16(14):2153–2166
Bergum JS, Li H (2007) Acceptance limits for the new ICH USP 29 content-uniformity test. Pharm Tech, October 2, 2007, www.pharmtech.com
Bergum JS, Utter ML (2000) Process validation. In: Chow SC (ed) Encyclopedia of biopharmaceutical statistics. Marcel Dekker, New York, pp 422–439
Bergum JS, Utter ML (2003) Statistical methods for uniformity and dissolution testing. In: Nash RA, Watchter AH (eds) Pharmaceutical process validation. Marcel Dekker, New York, pp 667–697. doi:667
Berman J (2001) The compliance and science of blend uniformity analysis. PDA J Pharm Sci Tech 55(4):209–222
Berman J, Planchard JA (1995) Blend uniformity and unit dose sampling. Drug Dev Ind Pharm 21(11):1257–1283
Berman J, Schoeneman A, Shelton JT (1996) Unit dose sampling – a tale of two thieves. Drug Dev Ind Pharm 22(11):1121–1132
Breunig HL, King EP (1962) Acceptance sampling of finished pharmaceutical products. J Pharm Sci 51(12):1187–1194
Chang RK, Shukla J, Buehler J (1996) An evaluation of a unit-dose compacting sample thief and a discussion of content uniformity testing and blending validation issues. Drug Dev Ind Pharm 22(9&10):1031–1035
Cochran WG (1977) Sampling techniques, 3rd edn. Wiley, New York, NY
Garcia T, Elsheimer B, Tarczynshi F (1995) Examination of components of variance for a production scale, low dose powder blend and resulting tablets. Drug Dev Ind Pharm 21(18):2035–2045
Garcia TP, Taylor MK, Pande GS (1998) Comparison of the performance of two sample thieves for the determination of the content uniformity of a powder blend. Pharm Dev Tech 3(1):7–12
Green RL, Thurau G, Pixley NC, Mateos A, Reed RA, Higgins JP (2005) In-line monitoring of moisture content in fluid bed dryers using near-IR spectroscopy with consideration of sampling effects on method accuracy. Anal Chem 77:4515–4522
Gy PM (1950) Formule donnant la masse minimale d’echantillon (A formula for the minimum sample mass), unpublished paper
Gy PM (1979) Sampling of particulate materials – theory and practice. Elsevier, Amsterdam
Gy PM (1998) Sampling for analytical purposes. Wiley, New York, NY
Gy PM (2004a) Sampling of discrete materials – a new introduction to the theory of sampling I: quantitative approach. Chemo and Intel Lab Sys 74:7–24
Gy PM (2004b) Sampling of discrete materials II: quantitative approach – sampling of zero-dimensional objects. Chemo and Intel Lab Sys 74:25–38
Gy PM (2004c) Sampling of discrete materials III: quantitative approach – sampling of one-dimensional objects. Chemo and Intel Lab Sys 74:39–47
Gy PM (2004d) Part IV: 50 years of sampling theory – a personal history. Chemo and Intel Lab Sys 74:49–60
Gy PM (2004e) Part V: annotated literature compilation of Pierre Gy. Chemo and Intel Lab Sys 74:61–70
Harwood CF, Ripley T (1977) Errors associated with the thief probe for bulk powder sampling. J Powder Bulk Solids Tech 11:20–29
Izenman FC (2001) Statistical and legal aspects of the forensic study of illicit drugs. Stat Sci 16(1):35–57
Kratochvil B, Wallace D, Taylor JK (1984) Sampling for chemical analysis. Anal Chem 56:113R–129R
Li W, Johnson AC, Bruce R, Rasmussen H, Worosila GD (2007) The effect of beam size on real-time determination of powder blend homogeneity by an on-line near infrared sensor. J Pharm Biomed Anal 43:711–717
Ma H, Anderson CA (2008) Characterization of powder blends by NIR chemical imaging. J Pharm Sci 97(8):3305–3320
MIL-STD-105E (1989) Military standard sampling procedures and tables for inspection by attributes. Supt. of Documents, US Government Printing Office, Washington, DC
MIL-STD-144 (1957) Military standard sampling procedures and tables for inspection by variables for percent defective. Supt. of Documents, US Government Printing Office, Washington, DC
Minkkinen P (2004) Practical applications of sampling theory. Chemo and Intel Lab Sys 74:85–94
Murray M, Uraizee S, Sakr A (1995) Preliminary investigation of the suitability of the USP uniformity of dosage units tests for evaluating the uniformity of powder blends and their corresponding tablets. Pharm Ind 57:256–262
Muzzio FJ, Roddy M, Brone D, Alexander AW, Sudah O (1999) An improved powder-sampling tool. Pharm Tech 23(4):92–110
Muzzio FJ, Goodridge CL, Alexander A, Arratia P, Yang H, Sudah O, Mergen G (2003) Sampling and characterization of pharmaceutical powders and granular blends. Int J Pharm 250:51–64
Petersen L, Minkkinen P, Esbensen KH (2005) Representative sampling for reliable data analysis: theory of sampling. Chemo and Intel Lab Sys 77:261–277
Portillo P, Muzzio FJ, Ierapetritou MG (2006) Characterizing powder mixing processes utilizing compartment models. Int J Pharm 320:14–22
Quackenbush FW, Rund RC (1967) The continuing problem of sampling. J Assoc Off Anal Chem 50:997–1006
Saranadasa H (2003) The square root of N plus one sampling rule – how much confidence do we have? Pharm Tech 27(5):50–62
The United States of America vs. Barr Laboratories, et al. (1993) 812, F. Supp. 458, District of New Jersey
Torbeck LD (2005) In defense of USP singlet testing. Pharm Tech 29(2):105–106
Torbeck LD (2009) Statistical solutions: square root of (N) + 1 sampling plan. Pharm Tech 33(10):108
Tsong Y, Hammerstrom T, Lin K, Ong TE (1995) Dissolution test acceptance sampling plans. J Biopharm Stat 5(2):171–183
United States FDA (2010) Investigations operations manual, collection technique, Sect. 4.3.7.2 Random sampling http://www.fda.gov/ICECI/Inspections/IOM/ucm122525.htm#4.3.7.2. Accessed 8 Aug 2010
United States Pharmacopeia 32 – National Formulary 27 (2009) US Pharmacopeial Convention, Rockville, MD, http://www.uspnf.com/uspnf/pub/index?usp=32&nf=27&s=2&officialOn=December%201,%202009. Accessed 8 Aug 2010
US FDA (1994) Division of field investigations, guide to inspections of oral solid dosage forms pre/post approval issues for development and validation. United States FDA, Silver Spring, MD
US FDA (1999) CEDR, Office for generic drugs, draft guidance for industry ANDAs: blend uniformity analysis (withdrawn in 2002). United States FDA, Silver Spring, MD
US FDA (2003) CEDR, Draft guidance for industry: powder blends and finished dosage units - stratified in-process dosage unit sampling and assessment. United States FDA, Silver Spring, MD
US FDA (2006) CEDR, Guidance for industry: investigating out-of-specification (OOS) test results for pharmaceutical production. United States FDA, Silver Spring, MD
USP <601> Aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers (2009) United States Pharmacopeia 32 – National Formulary 27, http://www.uspnf.com/uspnf/pub/index?usp=32&nf=27&s=2&officialOn=December%201,%202009. Accessed 8 Aug 2010
USP <711> Dissolution (2009) United States Pharmacopeia 32 – National Formulary 27, http://www.uspnf.com/uspnf/pub/index?usp=32&nf=27&s=2&officialOn=December%201,%202009. Accessed 8 Aug 2010
USP <905> Uniformity of dosage units (2009) United States Pharmacopeia 32 – National Formulary 27, http://www.uspnf.com/uspnf/pub/index?usp=32&nf=27&s=2&officialOn=December%201,%202009. Accessed 8 Aug 2010
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kou, D., Ma, H., Bishop, E.J., Zhan, S., Chokshi, H.P. (2011). Sampling Considerations. In: Nickerson, B. (eds) Sample Preparation of Pharmaceutical Dosage Forms. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9631-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9631-2_2
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-9630-5
Online ISBN: 978-1-4419-9631-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)